{"transactions":[{"id":574,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T20:22:41.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":19.6945,"value":49236.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.63 to $19.66, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."}],"balance_after":156155,"source":{"system":"sec-edgar","filing":"0001104659-26-104747","document":"tm2624688-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000110465926104747/tm2624688-1_4seq1.xml","form_type":"4"}},{"id":769042,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T19:28:29.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":6300,"price":15.9335,"value":100381.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.88 to $15.95, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."}],"balance_after":153655,"source":{"system":"sec-edgar","filing":"0001104659-26-065110","document":"tm2615373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465926065110/tm2615373-1_4seq1.xml","form_type":"4"}},{"id":804758,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-20T16:32:31.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":5618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person."}],"balance_after":147355,"source":{"system":"sec-edgar","filing":"0001104659-26-045359","document":"tm2612234-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465926045359/tm2612234-2_4seq1.xml","form_type":"4"}},{"id":1168819,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-21T17:41:04.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":13536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person."}],"balance_after":141737,"source":{"system":"sec-edgar","filing":"0001104659-25-036724","document":"tm2512762-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465925036724/tm2512762-5_4seq1.xml","form_type":"4"}},{"id":1431978,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T15:43:40.000Z","date":"2024-08-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":6.828,"value":27312.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 4 transactions at prices ranging from $6.78 to $6.91 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128201,"source":{"system":"sec-edgar","filing":"0001104659-24-090390","document":"tm2421907-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924090390/tm2421907-1_4seq1.xml","form_type":"4"}},{"id":1431977,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T15:43:40.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.707,"value":6707.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 6 transactions at prices ranging from $6.65 to $6.75 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":124201,"source":{"system":"sec-edgar","filing":"0001104659-24-090390","document":"tm2421907-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924090390/tm2421907-1_4seq1.xml","form_type":"4"}},{"id":1431976,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T15:43:40.000Z","date":"2024-08-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.526,"value":32630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 15 transactions at prices ranging from $6.40 to $6.66 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":123201,"source":{"system":"sec-edgar","filing":"0001104659-24-090390","document":"tm2421907-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924090390/tm2421907-1_4seq1.xml","form_type":"4"}},{"id":1504523,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:10:36.000Z","date":"2024-05-22","kind":"purchase","planned":false,"acquired":true,"shares":2109,"price":5.6263,"value":11865.8667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 5 transactions at prices ranging from $5.55 to $5.65 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":118201,"source":{"system":"sec-edgar","filing":"0001104659-24-064689","document":"tm2415420-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924064689/tm2415420-1_4seq1.xml","form_type":"4"}},{"id":1504522,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:10:36.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":12891,"price":5.5498,"value":71542.4718,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 26 transactions at prices ranging from $5.25 to $5.65 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":116092,"source":{"system":"sec-edgar","filing":"0001104659-24-064689","document":"tm2415420-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924064689/tm2415420-1_4seq1.xml","form_type":"4"}},{"id":1538030,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-04-22T20:05:26.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":11244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person."}],"balance_after":103201,"source":{"system":"sec-edgar","filing":"0001104659-24-049966","document":"tm2411391-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924049966/tm2411391-7_4seq1.xml","form_type":"4"}},{"id":1541616,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-17T01:46:56.000Z","date":"2024-04-13","kind":"exercise","planned":false,"acquired":true,"shares":6868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock issued upon the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 29, 2024, the Reporting Person filed Form 4/A and corrected the number of shares of the issuer's common stock directly beneficially owned by the Reporting Person as of May 18, 2023, which was 75,089 shares. The holdings reported on this Form 4 properly give cumulative effect to such correction in the original Form 4 as well as all intervening Forms 4 filed by the Reporting Person prior to the date hereof."}],"balance_after":91957,"source":{"system":"sec-edgar","filing":"0001104659-24-047983","document":"tm2411391-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465924047983/tm2411391-6_4seq1.xml","form_type":"4"}},{"id":1668750,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-29T21:28:00.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1742,"price":8.1,"value":14110.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I.  This amendment adjusts the holdings reported on Forms 4 for subsequent transactions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I.  This amendment adjusts the holdings reported on Forms 4 for subsequent transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I.  This amendment adjusts the holdings reported on Forms 4 for subsequent transactions."}],"balance_after":75089,"source":{"system":"sec-edgar","filing":"0000902959-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000090295924000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2023-05-26"}},{"id":1668749,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-29T21:18:32.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":1319,"price":7.21,"value":9509.99,"ownership":{"direct":true},"balance_after":73347,"source":{"system":"sec-edgar","filing":"0000902959-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000090295924000004/primary_doc.xml","form_type":"4"}},{"id":1668748,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-29T21:18:32.000Z","date":"2023-05-15","kind":"purchase","planned":false,"acquired":true,"shares":3681,"price":7.15,"value":26319.15,"ownership":{"direct":true},"balance_after":72028,"source":{"system":"sec-edgar","filing":"0000902959-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000090295924000004/primary_doc.xml","form_type":"4"}},{"id":1671468,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-26T00:11:36.000Z","date":"2023-04-13","kind":"grant","planned":false,"acquired":true,"shares":6868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan.  Each RSU represents the right to receive one share of Common Stock, subject to adjustment as provided in the Award Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person."}],"balance_after":6868,"derivative":{"underlying":"Common Stock","underlying_shares":6868},"source":{"system":"sec-edgar","filing":"0000902959-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000090295924000003/primary_doc.xml","form_type":"4"}},{"id":1784217,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T19:39:36.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":7.8467,"value":78467.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in 3 transactions at prices ranging from $7.78 to\n$7.85 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions &\nSupport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased\nat each separate price within the range set forth in this footnote."}],"balance_after":81393,"source":{"system":"sec-edgar","filing":"0001104659-23-099681","document":"tm2325896-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465923099681/tm2325896-1_4seq1.xml","form_type":"4"}},{"id":1875559,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T01:42:33.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1319,"price":7.15,"value":9430.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code."}],"balance_after":71393,"source":{"system":"sec-edgar","filing":"0001104659-23-066235","document":"tm2317189-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465923066235/tm2317189-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-05-26"}},{"id":1877337,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-27T00:56:15.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":1319,"price":7.15,"value":9430.85,"ownership":{"direct":true},"balance_after":68755,"source":{"system":"sec-edgar","filing":"0001104659-23-065593","document":"tm2317189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465923065593/tm2317189-1_4seq1.xml","form_type":"4"}},{"id":1916756,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T21:23:44.000Z","date":"2023-04-18","kind":"grant","planned":false,"acquired":true,"shares":1742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"A portion of the Reporting Person's stock based compensation for the year ended December 31, 2023. In connection with a previously disclosed stock grant on January 3, 2023, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January going forward. This grant represents the Reporting Person's stock-based compensation for the period running from January 1, 2023 through April 18, 2023."}],"balance_after":70074,"source":{"system":"sec-edgar","filing":"0001104659-23-047891","document":"tm2312625-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465923047891/tm2312625-6_4seq1.xml","form_type":"4"}},{"id":2064341,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:37:05.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":6088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2022. In connection with this issuance, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January for future periods."}],"balance_after":68332,"source":{"system":"sec-edgar","filing":"0001104659-23-001454","document":"tm232195-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465923001454/tm232195-4_4seq1.xml","form_type":"4"}},{"id":2266710,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:16:28.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":15000,"price":9.48,"value":142200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.47 to $9.48, inclusive."}],"balance_after":62244,"source":{"system":"sec-edgar","filing":"0001104659-22-062453","document":"tm2215987-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465922062453/tm2215987-1_4seq1.xml","form_type":"4"}},{"id":2266709,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:16:28.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":30000,"price":9.48,"value":284400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.67, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. (\"ISSC\"), any security holder of ISSC, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote or the following footnote to this Form 4."}],"balance_after":77244,"source":{"system":"sec-edgar","filing":"0001104659-22-062453","document":"tm2215987-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465922062453/tm2215987-1_4seq1.xml","form_type":"4"}},{"id":2452285,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T23:16:05.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2021."}],"balance_after":107244,"source":{"system":"sec-edgar","filing":"0001104659-22-001047","document":"tm221460-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465922001047/tm221460-1_4seq1.xml","form_type":"4"}},{"id":2831032,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T22:37:11.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":1139,"price":6.86,"value":7813.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.81 to $6.89, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. (\"ISSC\"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100895,"source":{"system":"sec-edgar","filing":"0001104659-21-029420","document":"tm217565-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921029420/tm217565-2_4seq1.xml","form_type":"4"}},{"id":2844549,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T00:42:50.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":8279,"price":6.88,"value":56959.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.85 to $6.92, inclusive."}],"balance_after":102034,"source":{"system":"sec-edgar","filing":"0001104659-21-026319","document":"tm217565-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921026319/tm217565-1_4seq1.xml","form_type":"4"}},{"id":2844548,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T00:42:50.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1200,"price":6.75,"value":8100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.76, inclusive."}],"balance_after":110313,"source":{"system":"sec-edgar","filing":"0001104659-21-026319","document":"tm217565-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921026319/tm217565-1_4seq1.xml","form_type":"4"}},{"id":2844547,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T00:42:50.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":900,"price":6.77,"value":6093.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.81, inclusive."}],"balance_after":111513,"source":{"system":"sec-edgar","filing":"0001104659-21-026319","document":"tm217565-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921026319/tm217565-1_4seq1.xml","form_type":"4"}},{"id":2844546,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T00:42:50.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":6500,"price":6.78,"value":44070.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.84, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. (\"ISSC\"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote or the following footnotes to this Form 4."}],"balance_after":112413,"source":{"system":"sec-edgar","filing":"0001104659-21-026319","document":"tm217565-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921026319/tm217565-1_4seq1.xml","form_type":"4"}},{"id":2917443,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:31:43.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":6872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2020."}],"balance_after":118913,"source":{"system":"sec-edgar","filing":"0001104659-21-001543","document":"tm211837-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465921001543/tm211837-2_4seq1.xml","form_type":"4"}},{"id":2936877,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-21T21:45:44.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":4276,"price":7.8,"value":33352.8,"ownership":{"direct":true},"balance_after":112041,"source":{"system":"sec-edgar","filing":"0001104659-20-138089","document":"tm2038957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465920138089/tm2038957-1_4seq1.xml","form_type":"4"}},{"id":3320128,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T01:32:38.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":18264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2019."}],"balance_after":116317,"source":{"system":"sec-edgar","filing":"0001104659-20-001722","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000110465920001722/a4.xml","form_type":"4"}},{"id":3516071,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T20:53:02.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":1000,"price":4.63,"value":4630.0,"ownership":{"direct":true},"balance_after":98053,"source":{"system":"sec-edgar","filing":"0001179110-19-006489","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911019006489/edgar.xml","form_type":"4"}},{"id":3519463,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T21:14:50.000Z","date":"2019-05-17","kind":"sale","acquired":false,"shares":7445,"price":4.6,"value":34247.0,"ownership":{"direct":true},"balance_after":99053,"source":{"system":"sec-edgar","filing":"0001179110-19-006397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911019006397/edgar.xml","form_type":"4"}},{"id":3519462,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T21:14:50.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":16555,"price":4.66,"value":77146.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $4.76, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. (\"ISSC\"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":106498,"source":{"system":"sec-edgar","filing":"0001179110-19-006397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911019006397/edgar.xml","form_type":"4"}},{"id":3706126,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:00:53.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":13377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2018."}],"balance_after":123053,"source":{"system":"sec-edgar","filing":"0001179110-19-000401","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911019000401/edgar.xml","form_type":"4"}},{"id":3889653,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T15:09:16.000Z","date":"2018-06-15","kind":"grant","acquired":false,"shares":1673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person received a restricted stock award of 1,673 shares of the Company's common stock on June 15, 2018. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant."}],"balance_after":27559,"source":{"system":"sec-edgar","filing":"0001192482-18-000305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000305/edgar.xml","form_type":"4"}},{"id":3926610,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-18T21:46:24.000Z","date":"2018-05-17","kind":"sale","acquired":false,"shares":25000,"price":50.89,"value":1272250.0,"ownership":{"direct":false,"nature":"As trustee of family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.89 to $51.72, inclusive."}],"balance_after":54387,"source":{"system":"sec-edgar","filing":"0001192482-18-000227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000227/edgar.xml","form_type":"4"}},{"id":3926609,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-18T21:46:24.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":2165,"price":48.27,"value":104504.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.15 to $48.49, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares received in a pro rata, in-kind distribution to partners by Originate Growth GP, LLC.  Such shares had previously been reported as being held indirectly by the Reporting Person through Originate Growth GP, LLC."}],"balance_after":25886,"source":{"system":"sec-edgar","filing":"0001192482-18-000227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000227/edgar.xml","form_type":"4"}},{"id":3926608,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-18T21:46:24.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":25000,"price":48.67,"value":1216750.0,"ownership":{"direct":false,"nature":"As trustee of family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.90 to $49.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (4) to this Form 4."}],"balance_after":79387,"source":{"system":"sec-edgar","filing":"0001192482-18-000227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000227/edgar.xml","form_type":"4"}},{"id":3985654,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-22T23:02:15.000Z","date":"2018-03-20","kind":"other","acquired":false,"shares":369929,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Originate Growth Fund 1A, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata, in-kind distribution to partners without consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth GP, LLC, Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Includes 2,545 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1A, L.P."}],"balance_after":2544,"source":{"system":"sec-edgar","filing":"0001192482-18-000137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000137/edgar.xml","form_type":"4"}},{"id":3985653,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-22T23:02:15.000Z","date":"2018-03-20","kind":"other","acquired":false,"shares":816910,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Originate Growth Fund 1Q, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata, in-kind distribution to partners without consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth GP, LLC, Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 5,616 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1Q, L.P."}],"balance_after":5617,"source":{"system":"sec-edgar","filing":"0001192482-18-000137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000137/edgar.xml","form_type":"4"}},{"id":3999416,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2018-03-13T19:03:58.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":72625,"price":25.85,"value":1877356.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":556969,"source":{"system":"sec-edgar","filing":"0001192482-18-000108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000108/edgar.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":3999415,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2018-03-13T19:03:58.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":237195,"price":25.85,"value":6131490.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":629594,"source":{"system":"sec-edgar","filing":"0001192482-18-000108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000108/edgar.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":3999414,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2018-03-13T19:03:29.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":160375,"price":25.85,"value":4145693.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1Q, L.P. (\"Originate #1Q\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":1229898,"source":{"system":"sec-edgar","filing":"0001192482-18-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000107/edgar.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":3999413,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2018-03-13T19:03:29.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":523805,"price":25.85,"value":13540359.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1Q, L.P. (\"Originate #1Q\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":1390723,"source":{"system":"sec-edgar","filing":"0001192482-18-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000107/edgar.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4038018,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T22:20:09.000Z","date":"2018-02-21","kind":"other","acquired":false,"shares":187039,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Originate Growth Fund 1A, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata, in-kind distribution to partners without consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Includes 2,544 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1A, L.P."}],"balance_after":372474,"source":{"system":"sec-edgar","filing":"0001192482-18-000096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000096/edgar.xml","form_type":"4"}},{"id":4038017,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T22:20:09.000Z","date":"2018-02-21","kind":"other","acquired":false,"shares":412989,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Originate Growth Fund 1Q, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata, in-kind distribution to partners without consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 5,617 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1Q, L.P."}],"balance_after":822526,"source":{"system":"sec-edgar","filing":"0001192482-18-000096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248218000096/edgar.xml","form_type":"4"}},{"id":4114949,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T22:46:04.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":11494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock based compensation for the year ended December 31, 2017."}],"balance_after":109676,"source":{"system":"sec-edgar","filing":"0001179110-18-000382","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911018000382/edgar.xml","form_type":"4"}},{"id":4135478,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:58:02.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":72625,"price":25.85,"value":1877356.25,"ownership":{"direct":false,"nature":"By: Originate Growth Fund #1A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC.  The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P.  Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":556969,"source":{"system":"sec-edgar","filing":"0001179110-17-015259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015259/edgar.xml","form_type":"4"}},{"id":4135477,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:58:02.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":237195,"price":25.85,"value":6131490.75,"ownership":{"direct":false,"nature":"By: Originate Growth Fund #1A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC.  The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P.  Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":629594,"source":{"system":"sec-edgar","filing":"0001179110-17-015259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015259/edgar.xml","form_type":"4"}},{"id":4135476,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:58:02.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":160375,"price":25.85,"value":4145693.75,"ownership":{"direct":false,"nature":"By: Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC.  The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P.  Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1229898,"source":{"system":"sec-edgar","filing":"0001179110-17-015259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015259/edgar.xml","form_type":"4"}},{"id":4135475,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:58:02.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":523805,"price":25.85,"value":13540359.25,"ownership":{"direct":false,"nature":"By: Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC.  The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P.  Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1390273,"source":{"system":"sec-edgar","filing":"0001179110-17-015259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015259/edgar.xml","form_type":"4"}},{"id":4135474,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":2,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":3,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":4,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:57:48.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":72625,"price":25.85,"value":1877356.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The shares are held by Originate #1A.  The general partner of Originate #1A is Originate GP, a limited liability company.  The members of Originate GP are Messrs. Bressner, Arnson and Gausling.  The members of Originate GP share voting and dispositive power over the shares held by Originate #1A.  Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":556969,"source":{"system":"sec-edgar","filing":"0001179110-17-015258","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015258/edgar.xml","form_type":"4"}},{"id":4135473,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":2,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":3,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":4,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:57:48.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":237195,"price":25.85,"value":6131490.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The shares are held by Originate #1A.  The general partner of Originate #1A is Originate GP, a limited liability company.  The members of Originate GP are Messrs. Bressner, Arnson and Gausling.  The members of Originate GP share voting and dispositive power over the shares held by Originate #1A.  Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":629594,"source":{"system":"sec-edgar","filing":"0001179110-17-015258","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015258/edgar.xml","form_type":"4"}},{"id":4135472,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":2,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":3,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":4,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:57:20.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":160375,"price":25.85,"value":4145693.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1Q, L.P. (\"Originate #1Q\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The shares are held by Originate #1Q.  The general partner of Originate #1Q is Originate GP, a limited liability company.  The members of Originate GP are Messrs. Bressner, Arnson and Gausling.  The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q.  Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.  In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":1229898,"source":{"system":"sec-edgar","filing":"0001179110-17-015256","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015256/edgar.xml","form_type":"4"}},{"id":4135471,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":2,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":3,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":4,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-12T21:57:20.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":523805,"price":25.85,"value":13540359.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report is filed jointly by Originate Growth Fund #1Q, L.P. (\"Originate #1Q\"), Originate Growth GP, LLC (\"Originate GP\"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling.  The shares are held by Originate #1Q.  The general partner of Originate #1Q is Originate GP, a limited liability company.  The members of Originate GP are Messrs. Bressner, Arnson and Gausling.  The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q.  Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.  In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis."}],"balance_after":1390273,"source":{"system":"sec-edgar","filing":"0001179110-17-015256","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000117911017015256/edgar.xml","form_type":"4"}},{"id":4276576,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T14:32:53.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Glen Bressner received a restricted stock award of 2,596 shares of the Company's common stock on June 16, 2017. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant."}],"balance_after":23161,"source":{"system":"sec-edgar","filing":"0001192482-17-000172","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248217000172/edgar.xml","form_type":"4"}},{"id":4310706,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T19:03:27.000Z","date":"2017-05-18","kind":"purchase","acquired":true,"shares":2309,"price":11.98,"value":27661.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $11.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20565,"source":{"system":"sec-edgar","filing":"0001192482-17-000128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248217000128/edgar.xml","form_type":"4"}},{"id":4310705,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T19:03:27.000Z","date":"2017-05-17","kind":"purchase","acquired":true,"shares":5191,"price":11.95,"value":62032.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.90 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18256,"source":{"system":"sec-edgar","filing":"0001192482-17-000128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248217000128/edgar.xml","form_type":"4"}},{"id":4489190,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-18T20:33:51.000Z","date":"2017-01-02","kind":"exercise","acquired":false,"shares":14234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14234},"source":{"system":"sec-edgar","filing":"0001179110-17-000984","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911017000984/edgar.xml","form_type":"4"}},{"id":4489189,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-18T20:33:51.000Z","date":"2017-01-02","kind":"exercise","acquired":true,"shares":14234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock."}],"balance_after":98182,"source":{"system":"sec-edgar","filing":"0001179110-17-000984","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911017000984/edgar.xml","form_type":"4"}},{"id":4585282,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":104589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":53912},"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585281,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":587158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":302659},"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585280,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":916766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":472560},"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585279,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":53912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":866789,"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585278,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":302659,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":812877,"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585277,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168369,"kind":"organization","name":"ORIGINATE GROWTH FUND 1A LP","position":1,"cik":"0001384604","reported_name":"ORIGINATE GROWTH FUND 1A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:26:15.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":472560,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1A, L.P. (\"Originate #1A\"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1A, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":510218,"source":{"system":"sec-edgar","filing":"0001192482-16-000723","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000723/edgar.xml","form_type":"4"}},{"id":4585276,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":335557,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":172967},"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585275,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":1883763,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":971012},"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585274,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":2941176,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1516070},"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585273,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"purchase","acquired":true,"shares":1000,"price":12,"value":12000.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Mr. Bressner's son. Mr. Bressner disclaims beneficial ownership of such shares."}],"balance_after":2794932,"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585272,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"purchase","acquired":true,"shares":7500,"price":12,"value":90000.0,"ownership":{"direct":true},"balance_after":2793932,"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585271,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":172967,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":2786432,"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585270,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":971012,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":2613465,"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585269,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:22:26.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":1516070,"ownership":{"direct":false,"nature":"By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., (\"Originate #1A\"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., (\"Originate #1Q\"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (h) 83,160 shares of common stock held by Originate #1Q."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1642453,"source":{"system":"sec-edgar","filing":"0001192482-16-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000720/edgar.xml","form_type":"4"}},{"id":4585382,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":230968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":119055},"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585381,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":1296605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":668353},"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585380,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":false,"shares":2024410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the \"Issuer\") common stock immediately prior to the closing of the initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1043510},"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585379,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":119055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1914078,"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585378,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":668353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1795023,"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585377,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":168367,"kind":"organization","name":"ORIGINATE GROWTH FUND 1Q LP","position":1,"cik":"0001384605","reported_name":"ORIGINATE GROWTH FUND 1Q LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168368,"kind":"organization","name":"Originate Growth GP, LLC","position":2,"cik":"0001685914","reported_name":"Originate Growth GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":3,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168350,"kind":"person","name":"Arnson Eric R","position":4,"cik":"0001685942","reported_name":"Arnson Eric R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168357,"kind":"person","name":"GAUSLING MICHAEL J","position":5,"cik":"0001125761","reported_name":"GAUSLING MICHAEL J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:18:08.000Z","date":"2016-10-04","kind":"exercise","acquired":true,"shares":1043510,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Originate Growth Fund #1Q, L.P. (\"Originate #1Q\") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This report is filed jointly by Originate #1Q, Originate Growth GP, LLC (\"Originate GP\"), Glen Bressner (\"Bressner\"), Eric Arnson (\"Arnson\"), and Michael Gausling (\"Gausling\"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest."}],"balance_after":1126670,"source":{"system":"sec-edgar","filing":"0001192482-16-000718","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902959/000119248216000718/edgar.xml","form_type":"4"}},{"id":4585362,"issuer":{"id":544,"kind":"organization","name":"INNOVATIVE SOLUTIONS & SUPPORT INC","symbol":"IA"},"owners":[{"id":545,"kind":"person","name":"BRESSNER GLEN R","position":1,"cik":"0000902959","reported_name":"BRESSNER GLEN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-10-05T15:46:57.000Z","date":"2015-11-12","kind":"grant","acquired":true,"shares":14234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock-based compensation for the year ending December 31, 2016."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest in full on January 2, 2017, provided that if the Reporting Person resigns from the Issuer's board of directors prior to January 1, 2017 he will receive a pro rated number of shares based on the number of days served as a director during 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest in full on January 2, 2017, provided that if the Reporting Person resigns from the Issuer's board of directors prior to January 1, 2017 he will receive a pro rated number of shares based on the number of days served as a director during 2016."}],"balance_after":14234,"derivative":{"underlying":"Common Stock","underlying_shares":14234},"source":{"system":"sec-edgar","filing":"0001179110-16-030422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836690/000117911016030422/edgar.xml","form_type":"4"}}]}